Geraint joined Sygnature Discovery in September 2005 with 13 years of drug discovery experience gained in biotechnology companies and CROs....
View Article
Geraint joined Sygnature Discovery in September 2005 with 13 years of drug discovery experience gained in biotechnology companies and CROs....
View Article
Colin joined Sygnature in May 2012 to take on a newly-created role managing computational science and informatics at Sygnature. He...
View Article
Joined Sygnature in September 2020 as Director and Head of Drug Abuse and Substance Use Disorders from Sosei Heptares. Andy has over 25...
View Article
Jane Kendrew joined Sygnature Discovery in June 2020 as Director of Translational Oncology. Jane has over 30 years drug discovery...
View Article
Meet Dave Pearson, the seasoned Director of Form and Formulation at Sygnature Discovery, leading the way with over 20 years of expertise in solid form and formulation science. From crystallinity to cGMP production, Dave optimizes molecules for clinic readiness. Discover how his vast experience drives success for clients and patients alike. PhD holder from the University of Sheffield, Dave bridges the gap between synthetic chemistry and patient-centric solutions
Alex joined Sygnature Discovery in September 2022 as the Director of Physical Chemistry, Drug Metabolism, and Pharmacokinetics. With over 30...
View Article
Rick joined Sygnature Discovery in January 2025 as Director of Protein Sciences and Structural Biology in the UK. With over...
View Article